3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Neoplasms, Germ Cell and Embryonal
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia
2
Hepatoblastoma
2
Glioblastoma
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Wilms Tumor
1
Uveal Melanoma
1
Skin Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Prostatic Neoplasms
1
Primary Malignant Peripheral Nerve Sheath Tumors
1
Ototoxicity
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Biopsy
3
Steroids
2
Hormones
2
Cyclin-Dependent Kinase Inhibitor p18
2
Cyclin-Dependent Kinase Inhibitor p16
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
taxane
1
radium Ra 223 dichloride
1
pertuzumab
1
naxitamab
1
eicosapentaenoic acid ethyl ester
1
eicosapentaenoic acid ethanolamide
1
binimetinib
1
abemaciclib
1
X-Rays
1
Trastuzumab
1
Taxoids
1
Taxes
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Photons
1
Paclitaxel
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Mastectomy, Simple
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage IV Breast Cancer AJCC v8
×
Vorinostat
×
1 year
×
Clear all
No trials found.